0002-7026Level 3
JAYPIRCA (pirtobrutinib)
**Product type:** Human Prescription Drug
**Active ingredient:** PIRTOBRUTINIB
**Strength:** 100 mg/1
**Dosage form:** Tablet, Coated
**Route:** Oral
**Labeler:** Eli Lilly and Company
**Marketing category:** NDA (NDA216059)
**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Bruton's Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0002-7026Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.